Page 868 - Williams Hematology ( PDFDrive )

842 Part VI: The Erythrocyte Chapter 54: Hemolytic Anemia Resulting from Immune Injury 843

162. Feizi T: Monotypic cold agglutinins in infection by Mycoplasma pneumoniae. Nature 198. Atkinson JP, Frank MM: Studies on in vivo effects of antibody: Interaction of IgM anti-
215:540, 1967. body and complement in the immune clearance and destruction of erythrocytes in
163. Feizi T, Loveless W: Carbohydrate recognition by Mycoplasma pneumoniae and patho- man. J Clin Invest 54:339, 1974.
logic consequences. Am J Respir Crit Care Med 154:S133, 1996. 199. Hughey CT, Brewer JW, Colosia AD, et al: Production of IgM hexamers by normal and
164. Mollison PL: Measurement of survival and destruction of red cells in haemolytic syn- autoimmune B cells: Implications for the physiologic role of hexameric IgM. J Immunol
dromes. Br Med Bull 15:59, 1959. 161:4091, 1998.
165. Hollander L: Erythrocyte survival time in a case of acquired haemolytic anaemia. Vox 200. Logue GL, Rosse WF, Gockerman JP: Measurement of the third component of com-
Sang 4:164, 1954. plement bound to red blood cells in patients with the cold agglutinin syndrome. J Clin
166. Chaplin H, Cohen R, Bloomberg G, et al: Pregnancy and idiopathic autoimmune Invest 52:493, 1973.
haemolytic anaemia: A prospective study during 6 months gestation and 3 months 201. Evans RS, Turner E, Bingham M: Studies with radioiodinated cold agglutinins of ten
“post-partum”. Br J Haematol 24:219, 1973. patients. Am J Med 38:378, 1965.
167. Mollison PL, Crome P, Hughes-Jones NC, Rochna E: Rate of removal from the circu- 202. Roelcke D: Cold agglutination: Antibodies and antigens. Clin Immunol Immunopathol
lation of red cells sensitized with different amounts of antibody. Br J Haematol 11:461, 2:266, 1974.
1965. 203. Mantovani B, Rabinovitch M, Nussenzweig V: Phagocytosis of immune complexes by
168. Mollison PL, Hughes-Jones NC: Clearance of Rh-positive red cells by low concentra- macrophages: Different roles of the macrophage receptor sites for complement (C3)
tion of Rh antibody. Immunology 12:63, 1967. and for immunoglobulin (IgG). J Exp Med 135:780, 1972.
169. Rosse WF: Quantitative immunology of immune hemolytic anemia: II. The relation- 204. Silverstein SC, Steinman RM, Cohn ZA: Endocytosis. Annu Rev Biochem 46:669, 1977.
ship of cell-bound antibody to hemolysis and the effect of treatment. J Clin Invest 205. Jaffe CH, Atkinson JP, Frank MM: The role of complement in the clearance of cold
50:734, 1971. agglutinin-sensitized erythrocytes in man. J Clin Invest 58:942, 1976.
170. Schreiber AD, Frank MM: Role of antibody and complement in the immune clearance 206. Brown DL, Nelson DA: Surface microfragmentation of red cells as a mechanism for
and destruction of erythrocytes: I. In vivo effects of IgG and IgM complement-fixing complement-mediated immune spherocytosis. Br J Haematol 24:301, 1973.
sites. J Clin Invest 51:575, 1972. 207. Evans RS, Turner E, Bingham M: Chronic hemolytic anemia due to cold agglutinins: I.
171. Atkinson JP, Schreiber AD, Frank MM: Effects of corticosteroids and splenectomy on The mechanism of resistance of red cells to C hemolysis by cold agglutinins. J Clin Invest
the immune clearance and destruction of erythrocytes. J Clin Invest 52:1509, 1973. 46:1461, 1967.
172. Atkinson JP, Frank MM: Complement independent clearance of IgG sensitized ery- 208. Kerr RO, Cardamone J, Dalmasso AP, Kaplan ME: Two mechanisms of erythrocyte
throcytes: Inhibition by cortisone. Blood 44:629, 1974. destruction in penicillin-induced hemolytic anemia. N Engl J Med 287:1322, 1972.
173. Jandl JH, Richardson-Jones A, Castle WB: The destruction of red cells by antibodies 209. Nesmith LW, Davis JW: Hemolytic anemia caused by penicillin. JAMA 203:27, 1968.
in man: I. Observations on the sequestration and lysis of red cells altered by immune 210. Yust I, Frisch B, Goldsher N: Simultaneous detection of two mechanisms of immune
mechanisms. J Clin Invest 36:1428, 1957. destruction of penicillin-treated human red blood cells. Am J Hematol 13:53, 1982.
174. Jandl JH, Kaplan ME: The destruction of red cells by antibodies in man: III. Quantita- 211. Brandriss MW, Smith JW, Steinman HG: Common antigenic determinants of penicillin
tive factors influencing the pattern of hemolysis in vivo. J Clin Invest 39:1145, 1960. G, cephalothin and 6-aminopenicillanic acid in rabbits. J Immunol 94:696, 1965.
175. Abramson N, LoBuglio AF, Jandl JH, Cotran RS: The interaction between human 212. Abraham GN, Petz LD, Fudenberg HH: Immuno-hematological cross-allergenicity
monocytes and red cells: Binding characteristics. J Exp Med 132:1191, 1970. between penicillin and cephalothin in humans. Clin Exp Immunol 3:343, 1968.
176. LoBuglio AF, Cotran RS, Jandl JH: Red cells coated with immunoglobulin G: Binding 213. Petz LD: Immunologic cross reactivity between penicillins and cephalosporins: A
and sphering by mononuclear cells in man. Science 158:1582, 1967. review. J Infect Dis 137:S74, 1978.
177. Anderson CL, Looney RJ: Human leukocyte IgG Fc receptors. Immunol Today 7:264, 214. Kunicki TJ, Russell N, Nurten AT, et al: Further studies of the human platelet receptor
1986. for quinine- and quinidine-dependent antibodies. J Immunol 126:398, 1981.
178. Ravetch JV, Kinet J-P: Fc receptors. Annu Rev Immunol 9:457, 1991. 215. Christie DJ, Aster RH: Drug-antibody-platelet interaction in quinine-and quinidine-
179. Gigli I, Nelson RA: Complement-dependent immune phagocytosis: I. Requirements of induced thrombocytopenia. J Clin Invest 70:989, 1982.
C1, C4, C2, C3. Exp Cell Res 51:45, 1968. 216. Berndt MC, Chong BH, Bull HA, et al: Molecular characterization of quinine/
180. Lay WF, Nussenzweig V: Receptors for complement on leukocytes. J Exp Med 128:991, quinidine drug-dependent antibody platelet interaction using monoclonal antisera.
1968. Blood 66:1292, 1985.
181. Ross GD: Opsonization and membrane complement receptors, in Immunobiology of 217. Sosler SD, Behzad O, Garratty G, et al: Acute hemolytic anemia associated with a
the Complement System, edited by GD Ross, p 87. Academic Press, Orlando, FL, 1986. chlorpropamide-induced apparent auto-anti-Jk . Transfusion 24:206, 1984.
a
182. Fischer JT, Petz LD, Garratty G, Cooper NR: Correlations between quantitative assay of 218. Salama A, Mueller-Eckhardt C: Rh blood group-specific antibodies in immune hemo-
red cell bound C3, serologic reactions, and hemolytic anemia. Blood 44:359, 1974. lytic anemia induced by nomifensine. Blood 68:1285, 1986.
183. Schreiber AD, Parsons J, McDermott P, Cooper RA: Effect of corticosteroids on the 219. Salama A, Mueller-Eckhardt C: On the mechanisms of sensitization and attachment of
human monocyte IgG and complement receptors. J Clin Invest 56:1189, 1975. antibodies to RBC in drug-induced immune hemolytic anemia. Blood 69:1006, 1987.
184. Ehlenberger AG, Nussenzweig V: The role of membrane receptors for C3b and C3d in 220. Christie DJ, Mullen PC, Aster RH: Fab-mediated binding of drug-dependent antibodies
phagocytosis. J Exp Med 145:357, 1977. to platelets in quinidine- and quinine-induced thrombocytopenia. J Clin Invest 75:310,
185. Rosse WF, De Boisfleury A, Bessis M: The interaction of phagocytic cells and red cells 1985.
modified by immune reactions: Comparison of antibody and complement coated red 221. Smith ME, Reid DM, Jones CE, et al: Binding of quinine- and quinidine-dependent
cells. Blood Cells 1:345, 1975. drug antibodies to platelets is mediated by the Fab domain of immunoglobulin G and
186. Dameshek W, Schwartz SO: Acute hemolytic anemia (acquired hemolytic icterus, acute is not Fc dependent. J Clin Invest 29:912, 1987.
type). Medicine (Baltimore) 19:231, 1940. 222. Salama A, Mueller-Eckhardt C: The role of metabolite-specific antibodies in nomifensine-
187. Leddy JP, Rosenfeld SI: Role of complement in hemolytic anemia and thrombocytope- dependent immune hemolytic anemia. N Engl J Med 313:469, 1985.
nia, in Immunobiology of the Complement System, edited by GD Ross, p 213. Academic 223. Kelton JG: Impaired reticuloendothelial function in patients treated with methyldopa.
Press, Orlando, FL, 1986. N Engl J Med 313:596, 1985.
188. Nicholson-Weller A, Burge J, Fearon DT, et al: Isolation of a human erythrocyte mem- 224. Bakemeier RF, Leddy JP: Erythrocyte autoantibody associated with alpha-methyldopa:
brane glycoprotein with decay-accelerating activity for C3 convertases of the comple- Heterogeneity of structure and specificity. Blood 32:1, 1968.
ment system. J Immunol 129:184, 1982. 225. Green FA, Jung CY, Rampal A, Lorusso DJ: Alpha-methyldopa and the erythrocyte
189. Lachmann PJ: The control of homologous lysis. Immunol Today 12:312, 1991. membrane. Clin Exp Immunol 40:554, 1980.
190. Packman CH: Pathogenesis and management of paroxysmal nocturnal hemoglobi- 226. Green Fa, Jung CY, Hui H: Modulation of alpha-methyldopa binding to the erythrocyte
nuria. Blood Rev 12:1, 1998. membrane by superoxide dismutase. Biochem Biophys Res Commun 95:1037, 1980.
191. Fleer A, Van Schaik ML, von dem Borne AE, Engelfriet CP: Destruction of sensitized 227. Kirtland HH III, Mohler DN, Horwitz DA: Methyldopa inhibition of suppressor-
erythrocytes by human monocytes in vitro: Effects of cytochalasin B, hydrocortisone lymphocyte function. A proposed cause of autoimmune hemolytic anemia. N Engl J
and colchicine. Scand J Immunol 8:515, 1978. Med 302:825, 1980.
192. Kurlander RJ, Rosse WF, Logue WL: Quantitative influence of antibody and comple- 228. Garratty G, Arndt P, Prince HE, Schulman IA: The effect of methyldopa and procain-
ment coating of red cells on monocyte-mediated cell lysis. J Clin Invest 61:1309, 1978. amide on suppressor cell activity in relation to red cell autoantibody production. Br J
193. Urbaniak SJ: Lymphoid cell dependent (K-cell) lysis of human erythrocytes sensitized Haematol 84:310, 1993.
with rhesus alloantibodies. Br J Haematol 33:409, 1976. 229. Dearden C, Wade R, Else M, et al: The prognostic significance of a positive direct anti-
194. Handwerger BS, Kay NW, Douglas SD: Lymphocyte-mediated antibody-dependent globulin test in chronic lymphocytic leukemia: A beneficial effect of the combination
cytolysis: Role in immune hemolysis. Vox Sang 34:276, 1978. of fludarabine and cyclophosphamide on the incidence of hemolytic anemia. Blood
195. Milgrom H, Shore SL: Lysis of antibody-coated human red cells by peripheral blood 111:1820, 2008.
mononuclear cells: Altered effector cell profile after treatment of target cells with 230. Borthakur G, O’Brien S, Wierda WG, et al: Immune anaemias in patients with chronic
enzymes. Cell Immunol 39:178, 1978. lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab-
196. Schreiber AD, Herskovitz BS, Goldwein M: Low-titer cold-hemagglutinin disease. N incidence and predictors. Br J Haematol 136:800, 2007.
Engl J Med 296:1490, 1977. 231. Spath P, Garratty G, Petz LD: Studies on the immune response to penicillin and
197. Evans RS, Turner E, Bingham M, Woods R: Chronic hemolytic anemia due to cold cephalothin in humans: II. Immunohematologic reactions to cephalothin administra-
agglutinins: II. The role of C in red cell destruction. J Clin Invest 47:691, 1968. tion. J Immunol 107:860, 1971.

Kaushansky_chapter 54_p0823-0846.indd 843 9/19/15 12:28 AM